Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02987621 · ClinicalTrials.gov registry record · NA
Can Transcranial Direct Current Stimulation Improve Ambulation and Fatigue Resistance in People With MS?
A NA study, sponsored by Colorado State University.
- Completed
- Registry status
- NA
- Development phase
- 14
- Enrollment target
NCT02987621 is a NA study that has completed, run by Colorado State University. The registered enrollment target is 14 participants.
The verdict
NCT02987621, a NA study, has completed, sponsored by Colorado State University.
- COMPLETED
- Registry status
- NA
- Development phase
- 14 participants
- Enrollment target
Study Summary
In this project the investigators will be using non-invasive brain stimulation on people with multiple sclerosis (PwMS) to improve leg muscle function. Two groups of participants will be recruited. One group will perform strength testing with and without the brain stimulation. The second group of participants will perform a fatigue task, pulling against a wire at a low level of force, with and without the brain stimulation. This type of brain stimulation has been shown to transiently improve strength and fatigue measures in other populations, e.g. aged, Parkinson's, and improve cognitive abilities in people with multiple sclerosis. It is the investigator's hope that the increases in performance seen in other patient groups will also occur in people with multiple sclerosis. Future investigations will look to apply the non-invasive brain stimulation technique during physical rehabilitation to improve short and long term outcomes related to physical function.
Interventions
- DEVICE tDCS
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2016-11 |
| Est. Completion | 2018-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02987621
The ClinicalTrials.gov registry entry for NCT02987621 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 14 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Colorado State University, which has 94 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which tDCS is the first listed.
NCT02987621 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02987621 about?
NCT02987621 is a clinical study titled "Can Transcranial Direct Current Stimulation Improve Ambulation and Fatigue Resistance in People With MS?". In this project the investigators will be using non-invasive brain stimulation on people with multiple sclerosis (PwMS) to improve leg muscle function. Two groups of participants will be recruited. One group will perform strength testing with and without the brain stimulation. The second group of pa...
What is the current status of trial NCT02987621?
This trial is currently completed. It is a NA study. The enrollment target is 14 participants. The study started on 2016-11. Estimated completion is 2018-06.
What interventions are being tested in trial NCT02987621?
The interventions under investigation include: tDCS (DEVICE).
Who is sponsoring clinical trial NCT02987621?
This trial is sponsored by Colorado State University, which has 94 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.